258 related articles for article (PubMed ID: 24474802)
1. Remote loading of preencapsulated drugs into stealth liposomes.
Sur S; Fries AC; Kinzler KW; Zhou S; Vogelstein B
Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2283-8. PubMed ID: 24474802
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and pharmacokinetics of liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs.
Chen H; Gao J; Wang F; Liang W
Drug Deliv; 2007 Apr; 14(4):201-8. PubMed ID: 17497352
[TBL] [Abstract][Full Text] [Related]
3. New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Ghelardini C; Mura P
Int J Pharm; 2010 Aug; 395(1-2):222-31. PubMed ID: 20594944
[TBL] [Abstract][Full Text] [Related]
4. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery.
Eloy JO; Claro de Souza M; Petrilli R; Barcellos JP; Lee RJ; Marchetti JM
Colloids Surf B Biointerfaces; 2014 Nov; 123():345-63. PubMed ID: 25280609
[TBL] [Abstract][Full Text] [Related]
5. Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes.
Zucker D; Barenholz Y
J Control Release; 2010 Sep; 146(3):326-33. PubMed ID: 20685223
[TBL] [Abstract][Full Text] [Related]
6. The influence of trapping agents on the antitumor efficacy of irinotecan liposomes: head-to-head comparison of ammonium sulfate, sulfobutylether-β-cyclodextrin and sucrose octasulfate.
Yang W; Yang Z; Fu J; Guo M; Sun B; Wei W; Liu D; Liu H
Biomater Sci; 2018 Dec; 7(1):419-428. PubMed ID: 30500018
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
[TBL] [Abstract][Full Text] [Related]
8. Amisulpride-CD-Loaded Liposomes: Optimization and In Vivo Evaluation.
Shukr MH; Ahmed Farid OA
AAPS PharmSciTech; 2018 Aug; 19(6):2658-2671. PubMed ID: 29943282
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation of trans-dehydrocrotonin in liposomes: an enhancement of the antitumor activity.
Lapenda TL; Morais WA; Almeida FJ; Ferraz MS; Lira MC; Santos NP; Maciel MA; Santos-Magalhães NS
J Biomed Nanotechnol; 2013 Mar; 9(3):499-510. PubMed ID: 23621007
[TBL] [Abstract][Full Text] [Related]
10. Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs.
Chen J; Lu WL; Gu W; Lu SS; Chen ZP; Cai BC; Yang XX
Expert Opin Drug Deliv; 2014 Apr; 11(4):565-77. PubMed ID: 24490763
[TBL] [Abstract][Full Text] [Related]
11. Clove essential oil-in-cyclodextrin-in-liposomes in the aqueous and lyophilized states: From laboratory to large scale using a membrane contactor.
Sebaaly C; Charcosset C; Stainmesse S; Fessi H; Greige-Gerges H
Carbohydr Polym; 2016 Mar; 138():75-85. PubMed ID: 26794740
[TBL] [Abstract][Full Text] [Related]
12. Physostigmine-loaded liposomes for extended prophylaxis against nerve agent poisoning.
Park JH; Lee JY; Kim KT; Joe HE; Cho HJ; Shin YK; Kim DD
Int J Pharm; 2018 Dec; 553(1-2):467-473. PubMed ID: 30389473
[TBL] [Abstract][Full Text] [Related]
13. Drug carriers based on cyclodextrin inclusion complexes for the controlled release of hydrophobic drugs.
Xiong L; Zheng L; Han K; Liu Q; Li Y; Liu W; Xia J; Wang W
J Control Release; 2011 Nov; 152 Suppl 1():e121-3. PubMed ID: 22195793
[No Abstract] [Full Text] [Related]
14. Study of glycol chitosan-carboxymethyl β-cyclodextrins as anticancer drugs carrier.
Tan H; Qin F; Chen D; Han S; Lu W; Yao X
Carbohydr Polym; 2013 Apr; 93(2):679-85. PubMed ID: 23499111
[TBL] [Abstract][Full Text] [Related]
15. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy.
Cai D; Gao W; He B; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2014 Feb; 35(7):2283-94. PubMed ID: 24360410
[TBL] [Abstract][Full Text] [Related]
17. Aptamer-based liposomes improve specific drug loading and release.
Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
[TBL] [Abstract][Full Text] [Related]
18. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
[TBL] [Abstract][Full Text] [Related]
19. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
20. Remote loading of curcumin-in-modified β-cyclodextrins into liposomes using a transmembrane pH gradient.
Odeh F; Nsairat H; Alshaer W; Alsotari S; Buqaien R; Ismail S; Awidi A; Al Bawab A
RSC Adv; 2019 Nov; 9(64):37148-37161. PubMed ID: 35542296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
